Literature DB >> 9140238

Practice guideline for the treatment of patients with Alzheimer's disease and other dementias of late life. American Psychiatric Association.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9140238     DOI: 10.1176/ajp.154.5.1

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  34 in total

Review 1.  Diagnosis and management of dementia in primary care at an early stage: the need for a new concept and an adapted procedure.

Authors:  J De Lepeleire; J Heyrman
Journal:  Theor Med Bioeth       Date:  1999-06

Review 2.  Clinical and economic factors in the treatment of behavioural and psychological symptoms of dementia.

Authors:  M E Hemels; K L Lanctôt; M Iskedjian; T R Einarson
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 3.  Complementary and alternative medicines in the treatment of dementia: an evidence-based review.

Authors:  Bruce Diamond; Susan Johnson; Kathleen Torsney; Jennifer Morodan; Brian Prokop; Dana Davidek; Patricia Kramer
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 4.  Tocopherol (vitamin E) in Alzheimer's disease and other neurodegenerative disorders.

Authors:  Karen Berman; Henry Brodaty
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

5.  The older adult driver with cognitive impairment: "It's a very frustrating life".

Authors:  David B Carr; Brian R Ott
Journal:  JAMA       Date:  2010-04-28       Impact factor: 56.272

Review 6.  Atypical antipsychotics for neuropsychiatric symptoms of dementia: malignant or maligned?

Authors:  Nathan Herrmann; Krista L Lanctôt
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

7.  On specialty pharmaceuticals: reflections of a second-year medical student.

Authors:  Ross E Breitbart
Journal:  Biotechnol Healthc       Date:  2006-10

Review 8.  Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors.

Authors:  Michael W Jann; Kara L Shirley; Gary W Small
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

9.  Documentation of antipsychotic use and indications for newly diagnosed, nonaggressive dementia patients.

Authors:  Nikhil Dhawan; Avila B Steele; Robert O Morgan; A Lynn Snow; Jessica A Davila; Mark E Kunik
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

Review 10.  Rivastigmine. A review of its use in Alzheimer's disease.

Authors:  C M Spencer; S Noble
Journal:  Drugs Aging       Date:  1998-11       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.